SIBNSI-BONE, Inc.
Surgical & Medical Instruments & Apparatus
- Revenue
- $201M
- 20% YoY
- Operating margin
- -11.1%
- 47% YoY
- EBITDA
- −$17M
- 46% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $3M net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCFired13% of revenueOver 10% of revenue
- Payouts exceed cash flowClear-6% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear—Over 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $90M | $106M | $139M | $167M | $201M | 20% |
| Operating income | −$52M | −$60M | −$47M | −$35M | −$22M | 37% |
| Net income | −$57M | −$61M | −$43M | −$31M | −$19M | 39% |
| Operating cash flow | −$40M | −$42M | −$19M | −$12M | −$675K | 95% |
| Capex | $6M | $10M | $8M | $10M | $8M | 20% |
| Stock-based comp | $17M | $23M | $24M | $26M | $26M | 1.3% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $1M · 8
- Net
- −$1M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $7M | $10M | 66 | 123 |
| FY2024 | — | — | 47 | 114 |
| FY2023 | — | — | 70 | 105 |
| FY2022 | — | — | 45 | 101 |
| FY2021 | — | — | 74 | 125 |